Partnership Model

TB vaccine research and development is complex and costly. No one organization or institution can do it alone. Aeras works in partnership with individuals, research organizations, academic institutions, funders, policymakers, and others to advance TB vaccine science. Due to limited resources and the complex biology of TB, it is crucial for scientists in this field to share knowledge and work together.

Some of Aeras’ partners include: